Aktienanalyse zu Oscar Health Inc (OSCR)OSCROscar Health Inc

Oscar Health, Inc. is a healthcare technology company built around a full-stack technology platform. The Company serves individuals, families, and employees through the Patient Protection and Affordable Care Act (ACA). It also offers health technology solutions that power the healthcare industry through +Oscar. It also wholly owns three businesses operating in the individual market: Lucie, Inc., a technology enrollment platform for consumers, employers and brokers; Trove Group Inc., an insurance agency that sells individual medical and supplemental health products, and HealthInsurance.org, LLC, a lead generation website providing educational content to help consumers navigate health insurance as well as the ACA and Medicare marketplaces. It operates in the Financials sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Oscar Health Inc is a good buy right now due to its current price of $33.37, which is significantly below the analyst price target of $42 from Raymond James, indicating a potential upside of 25.5%. Additionally, the company has shown strong earnings growth with a reported EPS of 1.10, a 155.81% surprise over estimates, and a robust year-to-date change of +122.91%. However, the main risk is the forward P/E ratio of 588.24, which suggests that the stock may be overvalued if growth expectations are not met.